Inhallation of e-cigarette cartridge solution aggravates allergen-induced airway inflammation and hyper-responsiveness in mice

被引：88

作者：

Lim H.B. ^{[1
]}

Kim S.H. ^{[2
]}

机构：

[1] Department of Industrial Crop Science and Technology, Chungbuk National University, Cheongju, Chungbuk

[2] Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon

来源：

Toxicological Research | 2014年 / 30卷 / 1期

关键词：

Airway hyperresponsiveness; Airway inflammation; Cytokine; Electronic cigarettes; Eosinophils; IgE;

D O I：

10.5487/TR.2014.30.1.013

中图分类号：

学科分类号：

摘要：

Electronic cigarettes (e-cigarettes) are becoming increasingly popular worldwide and their cellular effects warrant further evaluation. In this study, we investigated the effects of an e-cigarette cartridge solution on allergen related asthmatic airway inflammation (AI) and airway hyperresponsiveness (AHR), when it is delivered by intratracheal route in mice. Asthmatic AI and AHR were induced by systemic sensitization to ovalbumin (OVA) followed by intratracheal, intraperitoneal, and aerosol allergen challenges in BALB/c mice. The cartridge solution of e-cigarette (containing 16 mg/ml nicotine) was diluted 50 times and 100 μl of the diluted solution was intratracheally instilled to OVA-sensitized (OVA-S) mice two times a week for 10 weeks. Long-term e-cigarette inhalation elicited no remarkable changes in the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase enzymes in serum, however, increased infiltration of inflammatory cells including eosinophils, into airways from blood, aggravated the asthmatic AI and AHR, and stimulated the production of cytokines such as interleukin (IL)- 4, IL-5 and IL-13, and OVA-specific IgE production. Our data suggest that the inhalation of e-cigarette solutions can function as an important factor to exacerbate the allergy-induced asthma symptoms. Further studies are needed to address the effects of e-cigarette solutions on human health.

引用

页码：13 / 18

页数：5

共 28 条

[1]

Uryupin A.B., Peregudov A.S., Kochetkov K.A., Bulatnikova L.N., Kiselev S.S., Nekrasov Y.S., Qualitative and quantitative compositions of fluids for electronic cigarettes, Pharm. Chem. J., 46, pp. 687-692, (2013)

[2]

Polosa R., Caponnetto P., Morjaria J.B., Papale G., Campagna D., Russo C., Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study, BMC Public Health, 11, (2011)

[3]

Ingebrathsen B.J., Cole S.K., Alderman S.L., Electronic cigarette aerosol particle size distribution measurements, Inhalation Toxicol., 24, pp. 976-984, (2012)

[4]

Kuschner W.G., Reddy S., Mehrotra N., Paintal H.S., Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider, Int. J. Gen. Med., 4, pp. 115-120, (2011)

[5]

Lee S., Kimm H., Yun J.E., Jee S.H., Public health challenges of electric cigarettes in South Korea, J. Prev. Med. Public Health, 44, pp. 235-241, (2011)

[6]

Laugesen M., Safety report on the Ruyan e-cigarette cartridge and inhaled aerosol, pp. 1-23, (2008)

[7]

Summary of Results: Laboratory Analysis of Electronic Cigarettes Conducted By FDA, (2010)

[8]

Etter J.F., Electronic cigarettes: a survey of users, BMC Public Health, 10, (2010)

[9]

Caponnetto P., Auditore R., Russo C., Cappello G.C., Polosa R., Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: A prospective 12-month pilot study, Int. J. Environ. Res. Public Health, 10, pp. 446-461, (2013)

[10]

Flouris A.D., Chorti M.S., Poulianiti K.P., Jamurtas A.Z., Kostikas K., Tzatzarakis M.N., Wallace Hayes A., Tsatsakis A.M., Koutedakis T., Acute impact of active and passive electronic cigarette smoking on serum cotinin and lung function, Inhalation Toxicol., 25, pp. 91-101, (2013)

← 1 2 3 →